hit counter

Cytokine Profiles in Major Depression (Low IL-17C) & Comorbid Anxiety (2024 Study)

Recent studies have shed light on the intricate relationship between cytokines—proteins crucial for cell signaling in the immune system—depression, and anxiety. This exploration is pivotal in unveiling the potential biomarkers and therapeutic targets for major depressive disorder (MDD), particularly in patients experiencing their first episode and those untreated with drugs, with or without comorbid anxiety. …

Read more

Biomarkers in Major Depression: Interleukin-33 (IL-33) & Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) (2024 Study)

Major depressive disorder (MDD) is a complex mental health condition that significantly impacts individuals’ lives globally. A recent study evaluates the biological underpinnings of this disorder, focusing on two specific biomarkers: interleukin-33 (IL-33) and mesencephalic astrocyte-derived neurotrophic factor (MANF). These findings could pave the way for new diagnostic and treatment strategies. Highlights: Major depressive disorder …

Read more

Mycobacterium vaccae Vaccine: A Novel Soil Bacteria-Based Treatment for Anxiety & Stress Disorders

Stress can induce anxiety and depression, which appears to be mediated in part by stress-induced neuroinflammatory processes. The immunoregulatory bacterium Mycobacterium vaccae (M. vaccae) has anti-inflammatory and stress-resilient effects, but its impact on the brain is unclear. A study discovered that M. vaccae immunization: induces anti-inflammatory and immunoregulatory processes in the hippocampus, blocks stress-induced neuroinflammation …

Read more